日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Nxera Pharma to Get $10M from AbbVie for Neuro Project
Nxera Pharma Co., Ltd. has announced the achievement of a significant second…
Salesforce Launches Life Sciences Cloud for Engagement
Salesforce Japan Co., Ltd. announced the launch of "Life Sciences Cloud for…
Hitachi and ELITech Join Forces to Launch Fully Automated PCR System — A Turning Point for Diagnostics and Japan’s Tech Industry
Hitachi High-Tech Corporation announced that it has entered into a Collaboration, Manufacturing…
Lantheus and GE HealthCare partner on PYLARIFY in Japan
Lantheus Holdings, Inc. GE HealthCare and another company have signed an exclusive…
Genomenon Teams with Compass for Genomic Innovation
Genomenon, a leading genomic intelligence company, has announced a strategic partnership with…
FerroptoCure Inc Concludes Series A Round
Tokyo biotech startup FerroptoCure has raised ¥460 million in Series A funding.…
CRISPR and Beyond: Japan’s Strategic Blueprint for the Future of Gene Editing
Gene editing is no longer a lab experiment sitting in the background.…
FUJIFILM and argenx Extend Collaboration to U.S. Operations
FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding…
Latest Article
English